title: Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial.
authors.forename: George D
authors.initials: GD
authors.lastname: Kalliolias
authors.forename: Panagiotis E
authors.initials: PE
authors.lastname: Georgiou
authors.forename: Ioannis A
authors.initials: IA
authors.lastname: Antonopoulos
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Andonopoulos
authors.forename: Stamatis-Nick C
authors.initials: SN
authors.lastname: Liossis
mesh_terms: D000293:Adolescent; D000328:Adult; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016706:Still's Disease, Adult-Onset / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D053590:Interleukin 1 Receptor Antagonist Protein